EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Advances in Materials Science for Precision Melanoma Therapy: Nanotechnology-Enhanced Drug Delivery Systems

Sivakumar S Moni iD, Jobran M Moshi, Sabine Matou-Nasri iD, Shmoukh Alotaibi, Yousef M Hawsawi iD, Mohamed Eltaib Elmobark, Ahlam Mohammed S Hakami, Mohammed A Jeraiby iD, Ahmed A Sulayli, Hassan N Moafa iD

Pharmaceutics · 24.02.2025 · 17 (3) · 296

DOI: 10.3390/pharmaceutics17030296 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 24.02.2025. Verfasst von Sivakumar S Moni und 9 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Jazan University, Jazan 45142, Saudi Arabia. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 201 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deanship ‎of Graduate Studies and Scientific Research, Jazan University, Saudi Arabia, Deanship of Graduate Studies and Scientific Research, Jazan University, Saudi Arabia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Melanoma, a highly aggressive form of skin cancer, poses a major therapeutic challenge due to its metastatic potential, resistance to conventional therapies, and the complexity of the tumor microenvironment (TME). Materials science and nanotechnology advances have led to using nanocarriers such as liposomes, dendrimers, polymeric nanoparticles, and metallic nanoparticles as transformative solutions for precision melanoma therapy. This review summarizes findings from Web of Science, PubMed, EMBASE, Scopus, and Google Scholar and highlights the role of nanotechnology in overcoming melanoma treatment barriers. Nanoparticles facilitate passive and active targeting through mechanisms such as the enhanced permeability and retention (EPR) effect and functionalization with tumor-specific ligands, thereby improving the accuracy of drug delivery and reducing systemic toxicity. Stimuli-responsive systems and multi-stage targeting further improve therapeutic precision and overcome challenges such as poor tumor penetration and drug resistance. Emerging therapeutic platforms combine diagnostic imaging with therapeutic delivery, paving the way for personalized medicine. However, there are still issues with scalability, biocompatibility, and regulatory compliance. This comprehensive review highlights the potential of integrating nanotechnology with advances in genetics and proteomics, scalable, and patient-specific therapies. These interdisciplinary innovations promise to redefine the treatment of melanoma and provide safer, more effective, and more accessible treatments. Continued research is essential to bridge the gap between evidence-based scientific advances and clinical applications.

Schlagwörter

Stichwörter der Autor:innen

drug delivery systemsmaterials sciencemelanoma therapynanotechnologypersonalized medicinetargeted delivery systemtumor microenvironment

Autor:innen und Institutionen

  • College of Pharmacy, Jazan University, Jazan 45142, Saudi Arabia.
  • Health Research Centre, Jazan University, Jazan 45142, Saudi Arabia.
  • Department of Medical Laboratory Technology, College of Nursing and Health Science, Jazan University, Jazan 45142, Saudi Arabia.
  • Blood and Cancer Research Department, King Abdullah International Medical Research Center, King Saud bin Abdulaziz University for Health Sciences, Ministry of National Guard-Health Affairs, Riyadh 11481, Saudi Arabia.
  • Biosciences Department, Faculty of the School for Systems Biology, George Mason University, Manassas, VA 22030, USA.
  • Research Center, King Faisal Specialist Hospital and Research Center, Jeddah 23433, Saudi Arabia.

ORCID-Profile: Sivakumar S Moni, Sabine Matou-Nasri, Yousef M Hawsawi, Mohammed A Jeraiby, Hassan N Moafa

Förderung

  • Deanship ‎of Graduate Studies and Scientific Research, Jazan University, Saudi Arabia
  • Deanship of Graduate Studies and Scientific Research, Jazan University, Saudi Arabia

Zitieren

APA

Moni, S. S., Moshi, J. M., Matou-Nasri, S., Alotaibi, S., Hawsawi, Y. M., Elmobark, M. E., Hakami, A. M. S., Jeraiby, M. A., Sulayli, A. A., & Moafa, H. N. (2025). Advances in Materials Science for Precision Melanoma Therapy: Nanotechnology-Enhanced Drug Delivery Systems. Pharmaceutics, 17(3), 296. https://doi.org/10.3390/pharmaceutics17030296

Vancouver

Moni SS, Moshi JM, Matou-Nasri S, Alotaibi S, Hawsawi YM, Elmobark ME, et al. Advances in Materials Science for Precision Melanoma Therapy: Nanotechnology-Enhanced Drug Delivery Systems. Pharmaceutics. 2025;17(3):296. doi:10.3390/pharmaceutics17030296

BibTeX
@article{Moni2025,
  author = {Moni, Sivakumar S and Moshi, Jobran M and Matou-Nasri, Sabine and Alotaibi, Shmoukh and Hawsawi, Yousef M and Elmobark, Mohamed Eltaib and Hakami, Ahlam Mohammed S and Jeraiby, Mohammed A and Sulayli, Ahmed A and Moafa, Hassan N},
  title = {Advances in Materials Science for Precision Melanoma Therapy: Nanotechnology-Enhanced Drug Delivery Systems},
  journal = {Pharmaceutics},
  year = {2025},
  volume = {17},
  number = {3},
  pages = {296},
  doi = {10.3390/pharmaceutics17030296}
}
Kostenlos starten →